Evidence supports utility in biopsy-naïve patients, selected MRI-negative men with persistent clinical suspicion, repeat-biopsy settings, active surveillance, and local tumor staging, while combined mpMRI–microUS approaches have been shown to maximize yield of csPCa detection.
Navid Jabalameli, Feres Camargo Maluf, Fatema Bhinderwala et al.· Current Urology Reports· 0 citations
ML models using preoperative variables achieved moderate discrimination for predicting adverse pathological features in UTUC and external validation and prospective assessment of clinical utility are necessary before informing preoperative patient selection.
Philipp Korn, Maximilian Pallauf, S. Lokeshwar et al.· Urologic oncology· 0 citations
Magnetic resonance imaging radiomics shows promise in guiding the selection of patients most likely to benefit from the use of immune checkpoint inhibitor therapy in patients with very‐high‐risk, nonmuscle‐invasive bladder cancer. This work arrives at a moment of rapid expansion in bladder‐sparing therapeutics, even as...
Colton H Walker, Navid Jabalameli, S. Rais-Bahrami· Cancer· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.